Drugs Made In America Acquisition (DMII) Assets (2024 - 2025)
Drugs Made In America Acquisition (DMII) reported Assets of $505.0 million for Q4 2025, up 365643.31% year-over-year from N/an in Q4 2024, and up 0.79% on a QoQ basis from $501.0 million in Q3 2025.
Drugs Made In America Acquisition (DMII) has 2 years of Assets data on file, last reported at $505.0 million in Q4 2025.
- Quarterly Assets rose 365643.31% year-over-year to $505.0 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $505.0 million (up 365643.31% YoY) and the FY2025 annual result came in at $505.0 million, up 365643.31% from the prior year.
- Assets rose to $505.0 million in Q4 2025 per DMII's latest filing, from $501.0 million in the prior quarter.
- Across five years, Assets topped out at $505.0 million in Q4 2025 and bottomed at $138064.0 in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 474.42 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 311.76 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 310.95 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 310.55 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | 366.18 Mn |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 289.04 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 272.82 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 286.39 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 262.39 Mn |
| 10 | Drugs Made In America Acquisition | 128.97 Mn | 128.97 Mn | - | 504.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 504.96 Mn |
| Sep 30, 2025 | 501.01 Mn |
| Dec 31, 2024 | 138,064.00 |